{"organizations": [], "uuid": "659a5fdcaf2939c64cae5b1a44e233099263c39e", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://feeds.reuters.com/reuters/companyNews\r", "section_title": "Reuters: Company News", "url": "https://www.reuters.com/article/brief-rexahn-pharma-announces-appointmen/brief-rexahn-pharma-announces-appointment-of-douglas-j-swirsky-as-president-cfo-idUSASB0BZRU", "country": "US", "domain_rank": 408, "title": "BRIEF-Rexahn Pharma Announces Appointment Of Douglas J. Swirsky As President, CFO", "performance_score": 0, "site": "reuters.com", "participants_count": 0, "title_full": "", "spam_score": 0.0, "site_type": "news", "published": "2018-01-04T16:50:00.000+02:00", "replies_count": 0, "uuid": "659a5fdcaf2939c64cae5b1a44e233099263c39e"}, "author": "", "url": "https://www.reuters.com/article/brief-rexahn-pharma-announces-appointmen/brief-rexahn-pharma-announces-appointment-of-douglas-j-swirsky-as-president-cfo-idUSASB0BZRU", "ord_in_thread": 0, "title": "BRIEF-Rexahn Pharma Announces Appointment Of Douglas J. Swirsky As President, CFO", "locations": [], "entities": {"persons": [{"name": "douglas j. swirsky", "sentiment": "negative"}, {"name": "swirsky", "sentiment": "none"}], "locations": [], "organizations": [{"name": "brief-rexahn pharma", "sentiment": "negative"}, {"name": "rexahn pharmaceuticals inc", "sentiment": "none"}, {"name": "cfo reuters staff", "sentiment": "none"}, {"name": "reuters", "sentiment": "none"}, {"name": "eikon", "sentiment": "none"}, {"name": "genvec", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "January 4, 2018 / 2:52 PM / Updated 27 minutes ago BRIEF-Rexahn Pharma Announces Appointment Of Douglas J. Swirsky As President, CFO Reuters Staff \nJan 4 (Reuters) - Rexahn Pharmaceuticals Inc: \n* REXAHN PHARMACEUTICALS ANNOUNCES THE APPOINTMENT OF DOUGLAS J. SWIRSKY AS PRESIDENT AND CHIEF FINANCIAL OFFICER \n* REXAHN PHARMACEUTICALS INC - ‍SWIRSKY WAS MOST RECENTLY PRESIDENT, CEO AND A DIRECTOR OF GENVEC​ \n* REXAHN PHARMACEUTICALS INC - ‍ SWIRSKY REPLACES TAE HEUM JEONG WHO INFORMED COMPANY OF HIS RESIGNATION IN DECEMBER​ Source text for Eikon: Further company coverage:", "external_links": [], "published": "2018-01-04T16:50:00.000+02:00", "crawled": "2018-01-04T17:14:40.001+02:00", "highlightTitle": ""}